Rosetta Genomics Falls Short of Nasdaq Listing Requirement

The Israeli firm's stockholders' equity does not meet listing requirements and may face possible delisting action from Nasdaq.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.